Hepatotoxicity of Chemotherapy

Hepatotoxicity of Chemotherapy Paul D. King, Michael C. Perry Oncologist 2001; 6: 162-176 Author Information and Disclosures Target Audience: Physicians who wish to advance their current knowledge of clinical cancer medicine in hepatobiliary cancer and are involved in providing patient care in a cancer care environment. Method of Physician Participation: Read course materials, complete course quiz and evaluation form (optional). Learning Objectives After completing this course, the reader should be able to: Determine which chemotherapeutic drugs are hepatotoxins. Decide on dose modifications in the face of altered liver function tests. Understand the characteristic pattern of hepatoxicity induced by certain chemotherapeutic agents. The NIH/FAES designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CME Activity Information Accreditation CME Instructions For Credit Privacy Statement Hardware/Software Requirements Release Date: July 10, 2002 Most Recent Review: June 10, 2005* Most Recent Update: July 10, 2003 Date Credit Expires: Apr. 10, 2007 Time to Complete: 1 hour Medium: Internet Online *Click here to learn more about our review process.